ferric ferrocyanide has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, X; Li, X; Liu, Y; Niu, X; Wang, W; Yuan, Z; Zhang, Y | 1 |
| Chen, W; Feng, J; Hao, P; Lin, B; Liu, R; Liu, X; Wu, Y; Xu, Y; Yan, C; Yang, R; Zhang, J | 1 |
2 other study(ies) available for ferric ferrocyanide and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Near-infrared-light induced nanoparticles with enhanced tumor tissue penetration and intelligent drug release.
Topics: Animals; Cell Line, Tumor; Delayed-Action Preparations; Doxorubicin; Female; Ferrocyanides; Infrared Rays; Mammary Neoplasms, Experimental; Mice; Nanoparticles; Phototherapy | 2019 |
Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis.
Topics: Animals; Antibodies, Monoclonal; Cell Survival; Contrast Media; Female; Ferrocyanides; Integrin alphaVbeta3; Liposomes; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mammary Neoplasms, Experimental; Mice; Mice, SCID; Microscopy, Fluorescence; Neovascularization, Pathologic; Polyethylene Glycols | 2013 |